CUSIP: 33938J106
Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,054,774
-
Share change
-
-530,241
-
Total reported value
-
$81,592,598
-
Price per share
-
$13.48
-
Number of holders
-
41
-
Value change
-
-$10,076,470
-
Number of buys
-
24
-
Number of sells
-
17
Quarterly Holders Quick Answers
What is CUSIP 33938J106?
CUSIP 33938J106 identifies FLXN - FLEXION THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2014
-
Previous quarter:
Q1 2014
Recent filing periods for CUSIP 33938J106:
Institutional Holders of FLEXION THERAPEUTICS INC - COM (FLXN) as of Q2 2014
As of 30 Jun 2014,
FLEXION THERAPEUTICS INC - COM (FLXN) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,054,774 shares.
The largest 10 holders included
Novo A/S, JENNISON ASSOCIATES LLC, Capital World Investors, KINGDON CAPITAL MANAGEMENT, L.L.C., Redmile Group, LLC, Visium Asset Management, LP, JPMORGAN CHASE & CO, Broadfin Capital, LLC, WALL STREET ASSOCIATES, and BlackRock Fund Advisors.
This page lists
41
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.